Pharma/Medical Device

Shionogi Completes Acquisition of Sciele

Business Wire
October 10, 2008 - The deal was completed at a price of US$31.00 per share in cash....
Read Full Text
Add To My Watch List

Drug Firms Open Vaults in Search for TB Treatment

The Seattle Times
October 09, 2008 - Scientists at the Infectious Disease Research Institute are beginning to sort through more than 500,000 compounds in molecular libraries compiled by Eli Lilly and Merck....
Read Full Text
Add To My Watch List

Eli Lilly to Pay $62 Million Settlement

United Press International
October 08, 2008 - The company has settled claims with more than 30 state attorneys general that it improperly marketed the antipsychotic drug Zyprexa....
Read Full Text
Add To My Watch List

Eli Lilly to Buy ImClone for More Than $6B

Associated Press
October 07, 2008 - Bristol-Myers Squibb, ImClone's strategic partner, was also bidding to acquire the biotech firm....
Read Full Text
Add To My Watch List

Dendreon Shares Leap on Mixed News for Provenge

The Seattle Times
October 07, 2008 - The drug maker's prostate cancer treatment is awaiting FDA approval....
Read Full Text
Add To My Watch List

Roche Found to Infringe on Amgen's Anemia Drug Patents

Business Wire
October 06, 2008 - The U.S. District Court in Boston ruled last week that Amgen could enforce four patents on its version of the red blood cell booster erythropoietin....
Read Full Text
Add To My Watch List

E. Coli Vaccine for Cattle Developed by University of New Mexico

Market Wire
October 06, 2008 - GeneThera is in negotiations with the school to acquire worldwide development and distribution rights to the vaccine....
Read Full Text
Add To My Watch List

Merck Discontinues Obesity Drug Development

Business Wire
October 03, 2008 - The investigational drug taranabant had been in late-stage human trials, but dose-related adverse effects occurred too frequently....
Read Full Text
Add To My Watch List

Report: ImClone's Secret Suitor is Eli Lilly

Associated Press
October 02, 2008 - The biotech firm has repeatedly rejected takeover bids from its current strategic partner Bristol-Myers Squibb, saying it had a better deal from a previously undisclosed company....
Read Full Text
Add To My Watch List

Pfizer Shifts Focus to Cancer and Biotech Drugs

Associated Press
October 01, 2008 - The world's largest drug maker is ending new research on conditions from obesity to heart disease, but it will see late-stage research in those areas through to completion....
Read Full Text
Add To My Watch List
Results 1 - 10 of 36 1 2 3 4



Product Bulletins